Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Sichuan Huiyang Life Science and Technology Corporation
With
The initial cohort will be 3 subjects. Escalation to the next dose will continue unless a subject experiences a DLT, at which time a cohort will be expanded to up to 6 subjects. Provided there is only one DLT in that cohort, the dose will be escalated. However, if there are 2 DLTs in that cohort of up to 6 subjects, previous dose level will be expanded to total of 9 subjects. If none of the dose levels are acceptable at study completion (i.e., \>33% of subjects experiencing a DLT), an OD will not be identified, and the drug does not warrant further investigation.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
